Search

Search Constraints

You searched for: Author/Creator Champlin, Richard

Search Results

1. 1052. Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without prior hematopoietic cell transplant recipients. (31st December 2020)

2. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. (10th December 2020)

3. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. (9th November 2020)

4. Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case–control study. Issue 3 (24th January 2013)

5. Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis. Issue 3 (March 2015)

6. Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high‐dose cytarabine‐based induction chemotherapy. Issue 4 (7th March 2014)

7. Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. Issue 11 (24th January 2017)

8. Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma. Issue 8 (3rd August 2018)

9. Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China. Issue 7 (2nd July 2016)

10. Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma). (March 2019)